On Saturday morning, I took the kids to the farmer’s market and then Whole Foods. While at the store, Seth starting sneezing uncontrollably, presumably a reaction to some strong smelling body soaps on display at the store.
When we came home, my wife Anne gave the poor kid some generic children’s Benadryl. Ironically, I read this morning that Johnson & Johnson is recalling children’s Benadryl, Tylenol, Motrin and Zyrtec, according to The New York Times.
The recall involves all unexpired lots of seven products in 43 different flavors and sizes. These include Tylenol Infants’ Drops, Children’s Tylenol Suspensions, Infants’ Motrin Drops, Children’s Zyrtec liquids in bottles and Children’s Benadryl Allergy liquids.
Glad we usually by the generic. (At least in this case.)
Why the recall? Some of the products may contain more or less active ingredients than specified, according to the Johnson & Johnson subsidiary that sells the products. Concern over foreign particles – described as “metal specks” – also was expressed.
Details seem to be lacking, but that is nothing new because the Food and Drug Administration seems to spend as much time coddling manufacturers as it does overseeing them.
The agency says it’s investigating the problem, reports The Wall Street Journal:
“We want to be certain that consumers discontinue using these products and that they know what to do if they have concerns about a specific product,” FDA Commissioner Margaret Hamburg said in a statement. “While the potential for serious health problems is remote, Americans deserve medications that are safe, effective and of the highest quality.”
Right. That’s why the announcement was made on a Friday night, after it would have an immediate impact on Johnson & Johnson’s stock.